John M. Capek, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 46,900 shares at $85.00 ($4.0M) on 2019-06-20, disclosed to the SEC on 2019-06-21.
Open-market sale of $4.0M ABT by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ABT | SELL | 2020-04-23 | $9.6M | — | Filing → |
| ABT | SELL | 2018-07-26 | $4.2M | — | Filing → |
| ABT | SELL | 2017-02-22 | $4.2M | — | Filing → |